Drug Profile
Z 92
Latest Information Update: 28 Jun 2002
Price :
$50
*
At a glance
- Originator Psoraya Pharmaceuticals
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 12 May 2000 New profile
- 12 May 2000 Investigation in Psoriasis in USA (Topical)